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I
ntracellular parasitism deﬁnes the most intimate of
interactions between a pathogen and host. Inherent in
this equation are the needs of the pathogen to enter the
cell and establish a replication-permissive niche while
neutralizing and subverting cellular defenses. The protozoan
parasite Toxoplasma gondii is particularly adept at every stage
of intracellular parasitism, which has contributed to its being
among the most cosmopolitan parasites on the planet [1].
Toxoplasma is a member of the Apicomplexa, so noted by the
presence of specialized cytoskeletal and secretory organelles
(the apical complex) that play a critical role in invasion [2].
Most prominent among these secretory organelles are the
club-shaped rhoptries [3,4]. Recent work, including a detailed
cataloging of the rhoptry proteome [5], coupled with the
availability of the T. gondii genome and gene expression data
(http://www.ToxoDB.org; [6]), have resulted in new insights
into rhoptry functions. Among the activities inferred from
the analysis of the proteomic and genomic data was a family
of predicted serine threonine kinases related to the rhoptry
protein ROP2 [7]. While ROP2 and several other members of
the ROP2 family retain ‘‘molecular fossils,’’ reﬂecting their
ancestry as kinases, they do not possess kinase activity on
account of degeneracy and deletions at key catalytic sites [7].
However, bioinfomatic and structural prediction studies
reveal that two members, ROP16 and ROP18, do retain all the
elements needed to classify them as true kinases [7].
The focus of this Opinion is the rhoptry-derived kinase
ROP18, the initial biochemical analysis of which appears in
this issue of PLoS Pathogens from the laboratory of Jean
Franc ¸ois Dubremetz [8]. This characterization is particularly
timely given a pair of recent papers from the Boothroyd [9]
and Sibley [10] laboratories identifying ROP18 as a critical
contributor to virulence, a ﬁnding that represents the ﬁrst
virulence factor identiﬁed in Toxoplasma using classical
forward genetic approaches. I hope in this article to integrate
the results in these seminal papers and present them in the
context of Toxoplasma biology, virulence, and microbial
pathogenesis in general.
Rhoptries are unique secretory/excretory organelles found
exclusively in the Apicomplexa that are discharged at the
time of invasion and are critical in the establishment of a
productive infection [11,12]. Functional studies emanating
from the analysis of the rhoptry proteome [5] identiﬁed
factors critical in establishing the machinery for both parasite
invasion and the establishment of the nascent
parasitophorous vacuole [13,14]. The parasitophorous
vacuole, which deﬁnes the replication-permissive niche, is
delimited from the host cytoplasm by the parasitophorous
vacuole membrane (PVM), a remarkable and enigmatic
organelle in its own right [15]. To date, all proteins secreted
from the rhoptry either associate with the PVM or are
transported across it into the host cell cytoplasm [5,16].
Among these members of the ROP2 family are several
particularly interesting proteins. ROP2, the founding
member of this family, is secreted to the PVM at the time of
parasite invasion, where it is believed to establish itself as an
integral membrane protein with its N-terminus exposed to
the host cell cytoplasm [17]. The mechanism for membrane
association, however, is controversial in light of recent
molecular modeling analyses [7]. The presence of an N-
terminal signal on the secreted protein that is reminiscent of
a canonical mitochondrial import signal has implicated ROP2
as the mediator of the high afﬁnity binding of mitochondria
to the PVM [18,19]. The availability of the T. gondii genome
led the Dubremetz group to extend the ROP2 family to 16
members based upon both bioinformatic criteria and
functional proteomic data [7]. A somewhat surprising
revelation regarding the provenance of ROP2 family suggests
they have all evolved from a progenitor serine threonine
kinase on the basis of the presence of key signature motifs [7].
These motifs, however, have degenerated, particularly at the
N-terminus, where critical structural and sequence
components for kinase activity are either missing of
signiﬁcantly mutated in most of the members [7]. Most of
these degenerate ROP2 family members are predicted [7] or
have been demonstrated [20] to lack detectable kinase
activity. Interestingly, in most of these proteins lacking kinase
activity, the key structural element, a kinase fold at the C-
terminus, remains unchanged, which suggests a strong
selective pressure to retain it [7]. This fold in ROP2, and the
other closely related proteins, appear to be transmembrane
domains [17], which may suggest that a divergence of function
has accompanied the evolution of this family. What makes
ROP18 and ROP16 stand out in this family is that they retain
all of the bioinformatic and structural elements required to
designate them as putative functional kinases [7].
There is a signiﬁcant difference in the in silico prediction
of an enzymatic activity and its biochemical demonstration.
The studies described in this issue of the journal provide the
ﬁrst biochemical and functional data that deﬁne ROP18 as a
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location where an impact on parasite, host, or both parasite
and host factors can be predicted. While the identity of the
substrate for ROP18 remains elusive, it has been observed
that mature recombinant ROP18 selectively phosphorylates
an as yet unknown 70-kDa parasite protein, but not proteins
in host cell extracts [8]. This activity, however, is lost with an
engineered mutant with a critical active site mutation
(D394A) [8]. Together, these data represent the ﬁrst
functional biochemical validation of a rhoptry-derived
kinase. The authors report on multiple but futile attempts to
knock out ROP18, suggesting its activity may be essential. The
importance of ROP18 emerges in the observation that the
overexpression of the protein results in a dramatic increase
in parasite proliferation [8], an observation identical to that
made by Taylor et al. [10]. Critically, the same mutation
resulting in the loss of kinase activity (D394A) for ROP18 also
results in the loss of the accelerated growth phenotype [8].
Furthermore, the observation that the enhanced growth is
restricted to the vacuole overexpressing ROP18 in a doubly
infected cell argues for a localized effect that is unlikely to
directly impact changes within the infected cell, in effect
trans-complementing other wild-type vacuoles [8]. This is
consistent with the apparent failure of recombinant ROP18
to phosphorylate any host cell proteins [8]. With its
localization at the PVM, one might speculate about how this
kinase may impact parasite growth. The PVM, as the interface
between the parasite and the host, serves as a signaling
platform as well as the site for nutrient uptake [15]. One may
speculate that ROP18 is involved in phosphorylating a
substrate protein(s), thereby increasing the efﬁciency for the
uptake of a limiting nutrient. Whether the 70-kDa protein in
tachyzoite extracts that is phosphorylated by the recombinant
enzyme is secreted to the PVM, however, remains an open
question. What is known, however, is that another ROP2
family member, ROP4, serves as a substrate for an as yet
unknown kinase and is phosphorylated only in infected cells
[20].
The recent in silico structural analyses of the ROP2 family
have brought into question whether a domain that is critical
for kinase activity and annotated as a transmembrane domain
for ROP2 is in fact one [7]. If not, the mechanism for
anchoring ROP18 (and other ROP2 members) at the PVM
presents a dilemma complicated by the fact that ROP18 does
in fact have kinase activity [7]. In the PLoS paper by
Dubremetz and colleagues, an experiment designed to
examine the impact of expression of mature (like most other
ROP2 family members, ROP18 is proteolytically processed en
route to the rhoptry [7]) ROP18 in mammalian cells
presented a curious ﬁnding. ROP18 expressed in cells was
found to have no speciﬁc localization; however, infection of
such a cell resulted in the decoration of host cytoplasm–
expressed ROP18 at the PVM, suggesting a very speciﬁc
interaction [8]. It is possible, therefore, that ROP18 is in fact
secreted into the host cytoplasm and is bound by a speciﬁc
parasite adaptor molecule on the cytoplasmic aspect of the
PVM, thereby allowing the kinase fold designated for ROP2 as
a transmembrane domain [17] to serve its enzymatic function.
What makes all these activities associated with ROP18
particularly relevant are the recent publications from the
Boothroyd [9,21] and Sibley [10] laboratories identifying
ROP18 as an important virulence determinant. To
understand the importance of this work, a short primer on T.
gondii pathogenesis and virulence is presented.
T. gondii is a truly cosmopolitan parasite, with a host range
encompassing birds, terrestrial mammals, and marine
mammals [1]. Felines serve as the deﬁnitive host, as it is only
in their gastrointestinal tracts that the sexual cycle of the
parasite is manifest, resulting in the shedding of the
environmentally stable and highly infectious oocysts [1]. T.
gondii has evolved an additional means of transmission
mediated by tissue cysts in the muscles and organs of infected
intermediate hosts [1]. This transmission cycle by carnivory
has contributed to the explosion of the host range while
serving as a bottleneck for genetic diversity [22]. Despite is
ubiquitous host range, the population structure of the
parasite is remarkably narrow, with genetic analyses revealing
a largely clonal population structure, although a pool of
divergent ‘‘exotic’’ organisms persists [23–25]. Despite their
high homology, profound differences in acute virulence are
noted between strains. Accordingly, the hypervirulent Type I
strains are universally lethal in mice, with a single parasite
serving as the LD100 [25]. In contrast, the ‘‘avirulent’’ Type II
and III strains are much attenuated with an LD50 . 1000
organisms, a minimum 3 log difference [25]. Virulence is a
complex phenotype governed by factors including efﬁciency
of parasite growth, resistance to host defenses, and the
capacity to disseminate within the host. Among these
properties, rapid parasite growth and the immune and
physiological consequences of the increasing systemic
parasite burden serve as the strongest correlate to lethality in
vivo [26].
Performing genetic crosses of Toxoplasma is not trivial, as
they require the use of cats and the handling of large
concentrations of the highly infectious oocysts [27]. In the
papers from the Boothroyd and Sibley, group crosses were
conducted between the Type I 3 Type III (hypervirulent 3
avirulent) [10] and Type II 3 Type III (avirulent 3 avirulent)
[9] and the progeny examined for diverse virulence traits,
including mortality at deﬁned infective doses [9,10],
intracellular growth [10], migration (in soft agar and
transmigration of epithelia) [10], induction of host
transcriptional responses [9,21] and immune parameters,
including serum responses [10], and the capacity to induce
Th1 cytokines [9]. Mapping of the virulence-associated traits
by quantitative trait locus analysis revealed several loci across
the genome associated with the differences in the traits listed
above. Quantitative trait locus analysis, mapping by which is
dependent on genetic recombination, lacks the sensitivity to
pinpoint the responsible locus or gene. A quantitative trait
locus on chromosome VIIa drew particular attention, as its
impact was felt on multiple virulence-associated phenotypes.
Examination of this region (1.1 Mb with 140 predicted genes)
drew attention to one speciﬁc locus on account of its
predicted function, predicted localization of the protein, and
high density of polymorphisms between the different
clonotypes across the virulent (Type I) and avirulent (Types II
and II) parasites [9,10]. Conﬁrmation of the impact of strain-
speciﬁc polymorphisms at this locus on the virulence
phenotypes by the cross expression of strain-speciﬁc alleles in
the distinct genetic backgrounds reconﬁrmed its importance
as the key mediator responsible for the observed phenotypic
difference [9,10]. This locus turned out to be ROP18 [9,10],
the biochemical and functional characterization of which is
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Dubremetz group [8].
While a blockbuster in its own right, ROP18 turns out not
to be the only star of the ROP2 family (notwithstanding ROP2
itself, for which I have a personal affection). A locus on
chromosome VIIb was also found to be involved in the strain-
speciﬁc (TypeII versus TypeIII) differences in the capacity to
alter host transcriptional responses using genetic mapping
approaches [21]. This locus, ROP16, is also predicted to be an
active kinase [7,21], but, unlike ROP18, which remains at the
PVM [7,10], is translocated into the host cell nucleus [21]; this
is a property noted for a T. gondii–encoded protein,
phosphatase 2C [16]. This protein’s localization belies its
apparent function of impacting the host transcriptional
responses by subverting STAT3 and 6 signaling among the
targets for which key cytokines are involved in the immune
response to T. gondii [21]. Our own work reveals that T. gondii
subverts the transcriptional responses regulated by NFjB
using a parasite-encoded, PVM-localized activity capable of
phosphorylating the inhibitor of NFjB, IjBa [28,29]. We are
in the process of identifying this activity, which does not
appear to be rhoptry-localized, based on the kinetics of its
appearance at the PVM [29]. This all suggests that kinases and
likely other signaling activities such as phosphatases,
regulatory adaptors, and enzymatic modiﬁers (ubiquitin
ligases/de-ubiquitinating activities) delivered to the PVM play
a central role in the establishment of a productive infection.
An ongoing proteomic analysis (M. Martin, T. Liu, B. Lynn,
and A. Sinai, unpublished data) reveals evidence for all of
these activities at the PVM.
The exploitation of genomic and expression data, coupled
with large-scale proteomic screens, has set the stage for the
detailed dissection of complex phenotypes at the molecular
level. While the evolution of the ROP18 story presents a new
paradigm in microbial pathogenesis, many other important
questions in the biology of the parasite and the parasite–host
interaction remain wide open. &
Acknowledgments
I would like to thank J. Boothroyd, J. F. Dubremetz, and L. D. Sibley
for sharing information prior to their publication. Work in the Sinai
laboratory is supported by grants (AI49367 and AI062826) from the
US National Institutes of Health.
Author contributions. AS analyzed the data and wrote the paper.
Funding. The author received no speciﬁc funding for this article.
Competing interests. The author has declared that no competing
interests exist.
References
1. Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: From
animals to humans. Int J Parasitol 30: 1217–1258.
2. Dubremetz JF, Garcia-Reguet N, Conseil V, Fourmaux M (1998) Apical
organelles and host cell invasion by Apicomplexa. Int J Parsitol 28: 1007–
1013.
3. Blackman MJ, Bannister LH (2001) Apical organelles of Apicomplexa:
Biology and isolation by subcellular fractionation. Mol Biochem Parasitol
117: 11–25.
4. DeSouza W, Souto-Padron T (1978) Ultrastructural localization of basic
proteins on the conoid, rhoptries and micronemes of Toxoplasma gondii.Z
Parasitenkd 56: 123–129.
5. Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, et al. (2005)
Proteomic analysis of rhoptry organelles reveals many novel constituents
for host–parasite interactions in Toxoplasma gondii. J Biol Chem 280:
34245–34258.
6. Kissinger JC, Gajria B, Li L, Paulsen IT, Roos DS (2003) ToxoDB: Accessing
the Toxoplasma gondii genome. Nucleic Acids Res 31: 234–236.
7. El Hajj H, Demey E, Poncet J, Lebrun M, Wu B, et al. (2006) The ROP2
family of Toxoplasma gondii rhoptry proteins: Proteomic and genomic
characterization and molecular modeling. Proteomics 6: 5773–5784.
8. El Hajj H, Lebrun M, Arold S, Vial H, Labesse G, et al. (2007) ROP18 is a
rhoptry kinase controlling the intracellular proliferation of Toxoplasma
gondii. PLoS Pathog 3: e14. doi:10.1371/journal.ppat.0030014
9. Saeij J, Boyle J, Coller S, Taylor S, Sibley L, et al. (2006) Polymorphic
secreted kinases are virulence factors in toxoplasmosis. Sciecne 314: 1780–
1783.
10. Taylor S, Barragan A, Su C, Fux B, Fentress S, et al. (2006) A secreted
serine-threonine kinase determines virulence in the eukaryotic pathogen
Toxoplasma gondii. Science 314: 1776–1780.
11. Perkins M (1992) Rhoptry organelles of apicomplexan parasites. Parasitol
Today 8: 28–32.
12. Nichols BA, Chiappino ML, O’Connor GR (1983) Secretion from the
rhoptries of Toxoplasma gondii during host-cell invasion. J Ultrastruct Res
83: 85–98.
13. Lebrun M, Michelin A, El Hajj H, Poncet J, Bradley PJ, et al. (2005) The
rhoptry neck protein RON4 relocalizes at the moving junction during
Toxoplasma gondii invasion. Cell Microbiol 7: 1823–1833.
14. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC (2005)
Identiﬁcation of the Moving Junction Complex of Toxoplasma gondii: A
collaboration between distinct secretory organelles. PLoS Pathog 1: e17.
doi:10.1371/journal.ppat.0010017
15. Martin A, Liu T, Lynn B, Sinai A (2007) The Toxoplasma gondii
parasitophorous vacuole membrane: Transactions across the border. J
Eukaryot Microbiol. E-pub 12 December 2006. doi:10.1111/j.1550–7408.
2006.00230.x
16. Gilbert L, Ravindran S, Turetzky J, Boothroyd JC, Bradley PJ (2007)
Toxoplasma gondii targets a protein phosphatase 2C to the nucleus of
infected host cells. Eukaryot Cell 6: 73–83. doi:10.1128/EC.00309-06
17. Beckers CJM, Dubremetz JF, Mercereau-Puijalon O, Joiner KA (1994) The
Toxoplasma gondii rhoptry protein ROP2 is inserted into the
parasitophorous vacuole membrane, surrounding the intracellular
parasite, and is exposed to the host cell cytoplasm. J Cell Biol 127: 947–
961.
18. Sinai AP, Joiner KA (2001) The Toxoplasma gondii protein ROP2 mediates
host organelle association with the parasitophorous vacuole membrane. J
Cell Biol 154: 95–108.
19. Sinai AP, Webster P, Joiner KA (1997) Association of host cell endoplasmic
reticulum and mitochondria with the Toxoplasma gondii parasitophorous
vacuole membrane: A high afﬁnity interaction. J Cell Sci 110: 2117–2128.
20. Carey KL, Jongco AM, Kim K, Ward GE (2004) The Toxoplasma gondii
rhoptry protein ROP4 is secreted into the parasitophorous vacuole and
becomes phosphorylated in infected cells. Eukaryot Cell 3: 1320–1330.
21. Saeij J, Coller S, Boyle J, Jerome M, White M, et al. (2007) Toxoplasma co-
opts host gene expression by injection of a polymorphic kinase
homologue. Nature 445: 324–327. doi:10.1038/nature05395
22. Sibley L (2003) Recent origins among ancient parasites. Vet Parasitol 15:
185–198.
23. Khan A, Taylor S, Su C, Mackey A, Boyle J, et al. (2005) Composite genome
map and recombination parameters derived from the three archetypal
lineages of Toxoplasma gondii. Nucleic Acids Res 33: 2980–2992.
24. Boyle J, Rajasekar B, Saeij J, Ajioka J, Berriman M, et al. (2006) Just one
cross appears capable of dramatically altering the population biology of a
eukaryotic pathogen like Toxoplasma gondii. Proc Natl Acad Sci U S A 103:
10514–10519.
25. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii
comprise a single clonal lineage. Nature 359: 82–85.
26. Saeij JP, Boyle JP, Boothroyd JC (2005) Differences among the three major
strains of Toxoplasma gondii and their speciﬁc interactions with the infected
host. Trends Parasitol 21: 476–481.
27. Sibley LD, Mordue DG, Su C, Robben PM, Howe DK (2002) Genetic
approaches to studying virulence and pathogenesis in Toxoplasma gondii.
Philos Trans R Soc Lond B Biol Sci 357: 81–88.
28. Molestina RE, Sinai AP (2005) Detection of a novel parasite kinase activity
at the Toxoplasma gondii parasitophorous vacuole membrane capable of
phosphorylating host IkBa. Cell Microbiol 7: 351–362.
29. Molestina RE, Sinai AP (2005) Host and parasite-derived IKK activities
direct distinct temporal phases of NF-kappaB activation and target gene
expression following Toxoplasma gondii infection. J Cell Sci 118: 5785–5796.
PLoS Pathogens | www.plospathogens.org February 2007 | Volume 3 | Issue 2 | e16 0137